In contrast, APLP2 expression was reduced in clear cell renal cell carcinoma, and low APLP2 levels corresponded to worse patient outcomes, suggesting that APLP2 may have a dynamic role that varies among cancer types (31). The gene discussed is APLP2; the disease is cancer.